ICON Plc (ICLR) – Company Profile and SWOT Analysis

ICON Plc (ICLR) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

ICON Plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. The company provides specialized services that span the entire lifecycle of product development. ICON’s service portfolio includes adaptive trials, biosimilars, clinical research services, commercialization and outcomes, consulting, provision of functional services, medical imaging, resourcing solutions, laboratory services and strategic support and tactical solutions for traditional, in vitro diagnostic and software devices. The company offers research services in areas of cancer, genomics, central nervous system, cardiovascular, endocrine and metabolic disorders, gastrointestinal, medical device, non-alcoholic steatohepatitis (NASH), ophthalmology, rare and orphan diseases, transplant and immunology, vaccines, and women’s health, among others. ICON is headquartered in Dublin, Ireland.

Scope

• Detailed information on ICON Plc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting ICON Plc in the form of a SWOT analysis

• An in-depth view of the business model of ICON Plc including a breakdown and examination of key business segments

• News about ICON Plc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of ICON Plc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess ICON Plc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on ICON Plcs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Thermo Fisher Scientific Inc

Syneos Health Inc

Laboratory Corp of America Holdings

IQVIA Holdings Inc

Fortrea Inc

Parexel International Corp

Almac Group Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

ICON Plc - Key Facts

ICON Plc - Key Employees

ICON Plc - Key Employee Biographies

ICON Plc - Major Products and Services

ICON Plc - History

ICON Plc - Company Statement

ICON Plc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

ICON Plc - Business Description

Geographical Segment: Ireland

Performance

Geographical Segment: Other

Performance

Geographical Segment: Rest of Europe

Performance

Geographical Segment: U.S.

Performance

R&D Overview

ICON Plc - Corporate Strategy

ICON Plc - SWOT Analysis

SWOT Analysis - Overview

ICON Plc - Strengths

ICON Plc - Weaknesses

ICON Plc - Opportunities

ICON Plc - Threats

ICON Plc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences, Oil & Gas Financial Deals and Alliances

ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025

ICON Plc, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025

ICON Plc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jul 23, 2025: ICON Reports Second Quarter 2025 Results

Jul 16, 2025: ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report

Jun 23, 2025: ICON Schedules Second Quarter 2025 Earnings Conference Call

May 07, 2025: Global Icon Survey Shows Need for More Efficient Obesity Clinical Trial Design to Realise Full Potential of Next-Gen Multi-Indication Therapies

Feb 19, 2025: ICON reports fourth quarter and full year 2024 results

Jan 30, 2025: Icon Portfolio of AI Tools Drives Clinical Trial Efficiencies

Dec 18, 2024: ICON announces Appointment of Chief Operating Officer

Sep 03, 2024: ICON to Present at the Baird 2024 Global Healthcare Conference

Aug 14, 2024: ICON Announces Appointment of New Chief Financial Officer

Jul 24, 2024: ICON Announces Results of Annual General Meeting and Changes to the Board of Directors

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

ICON Plc, Key Facts

ICON Plc, Key Employees

ICON Plc, Key Employee Biographies

ICON Plc, Major Products and Services

ICON Plc, History

ICON Plc, Subsidiaries

ICON Plc, Key Competitors

ICON Plc, Ratios based on current share price

ICON Plc, Annual Ratios

ICON Plc, Annual Ratios (Cont…1)

ICON Plc, Annual Ratios (Cont…2)

ICON Plc, Interim Ratios

ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025

ICON Plc, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025

ICON Plc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

ICON Plc, Performance Chart (2020 – 2024)

ICON Plc, Ratio Charts

ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025

ICON Plc, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports